A drug used to treat amyotrophic lateral sclerosis, or Lou Gehrig’s disease, has been found to increase the risk of developing Parkinson’s, according to a study published in the journal Neurology.
The drug, known as Lantus, is used to fight amyotrophin-releasing hormone receptor (ARH) deficiency and may also lower the risk for Parkinson’s by increasing the levels of the brain chemical dopamine.
But the study also found that using the drug to treat Alzheimer’s disease also increased the risk, and it also had a strong association with increased risk for stroke.
The research team included researchers from the University of Toronto, McGill University, the University College London and the University Hospital Zurich.
Parkinson’s is a degenerative neurological disease caused by a degenerating nerve cell in the brain.
It causes symptoms that are usually mild or nonexistent, but can worsen over time.
Parkinsonism is typically treated with drugs that increase dopamine, such as dopamine agonists.
Lantuses are often prescribed to people with Parkinson’s who are not at high risk for the disease, but they can also be used for people with other neurological conditions, such the amyotropheptics disease, or amyotrophy disease, the authors of the study wrote.
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disorder that affects nerve cells in the central nervous system.
It affects more than 500,000 people worldwide, and about half of those have Alzheimer’s, said Dr. Daniel Lohr, a professor of neurology and neurosurgery at the University at Buffalo.
The disease affects people of all ages and levels of intelligence, he said.
It can cause weakness, stiffness and sometimes memory loss, although symptoms are often mild.
Amyatrophic lateral sclerosis is more common in people over 65.
The researchers studied about 5,000 cases of amyotropic lateral sclerosis in people ages 50 to 70 and 8,000 patients ages 70 to 80.
About 2,000 of those patients had a positive diagnosis of Parkinson’s.
About 10 percent had a history of Parkinsonism.
About half had symptoms of a stroke or a history and treatment with another drug or treatment for Alzheimer’s.
“These findings suggest that Parkinson’s drug use may increase risk for patients with ALS,” the researchers wrote.
The drugs that increased the likelihood of developing Alzheimer’s included Lantues dopamine agonist, Lantussin, a dopamine agonism that can be given intravenously.
Lantsin increases the level of dopamine in the blood, but also increases the dopamine in brain cells, and this can increase the rate at which the dopamine builds up in the cells.
This can lead to a buildup of dopamine and may lead to inflammation and damage to the brain cells.
It also decreases the amount of dopamine, making it less accessible to the neurons.
Lantoquin, a medication also used to manage Parkinson’s symptoms, increased the level in the body, but it also increased blood flow in the neurons and prevented the buildup of excess dopamine.
The medications were found to have a stronger association with Parkinsonism than those that did not increase the levels.
“Although the association between Parkinson’s and Lantuas is strong, the dose and duration of use of these drugs is not consistent,” the authors wrote.
Lantis, a benzodiazepine that is used in anxiety disorders, has also been linked to an increased risk of Parkinsonia.
It has been shown to increase dopamine levels in the brains of patients with Parkinson disease.
Lanteans use of Lantuns use of other drugs may also increase the amount or type of dopamine released from neurons, leading to an increase in inflammation and loss of nerve cells, the researchers said.